BR112012003560A8 - bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica - Google Patents

bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica

Info

Publication number
BR112012003560A8
BR112012003560A8 BR112012003560A BR112012003560A BR112012003560A8 BR 112012003560 A8 BR112012003560 A8 BR 112012003560A8 BR 112012003560 A BR112012003560 A BR 112012003560A BR 112012003560 A BR112012003560 A BR 112012003560A BR 112012003560 A8 BR112012003560 A8 BR 112012003560A8
Authority
BR
Brazil
Prior art keywords
alcoholic beverage
producing
pharmaceutical composition
compositions
alcoholic
Prior art date
Application number
BR112012003560A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112012003560A2 (pt
Inventor
Czarnik Anthony
McKinney Jeffrey
Original Assignee
Protia Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protia Llc filed Critical Protia Llc
Publication of BR112012003560A2 publication Critical patent/BR112012003560A2/pt
Publication of BR112012003560A8 publication Critical patent/BR112012003560A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12CBEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C12/00Processes specially adapted for making special kinds of beer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/04Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
BR112012003560A 2009-08-21 2010-08-20 bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica BR112012003560A8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US27487509P 2009-08-21 2009-08-21
US61/274,875 2009-08-21
US28086009P 2009-11-09 2009-11-09
US61/280,860 2009-11-09
US28352409P 2009-12-04 2009-12-04
US61/283,524 2009-12-04
US12/777,238 US8658236B2 (en) 2009-08-21 2010-05-10 Alcoholic compositions having a lowered risk of acetaldehydemia
US12/777,238 2010-05-10
PCT/US2010/046211 WO2011022682A1 (en) 2009-08-21 2010-08-20 Alcoholic compositions having a lowered risk of acetaldehydemia

Publications (2)

Publication Number Publication Date
BR112012003560A2 BR112012003560A2 (pt) 2020-10-27
BR112012003560A8 true BR112012003560A8 (pt) 2020-12-01

Family

ID=43605849

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012003560A BR112012003560A8 (pt) 2009-08-21 2010-08-20 bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica

Country Status (32)

Country Link
US (6) US8658236B2 (https=)
EP (1) EP2467465B1 (https=)
JP (1) JP5862965B2 (https=)
KR (1) KR101462740B1 (https=)
CN (2) CN103300449B (https=)
AP (1) AP3676A (https=)
AU (1) AU2010284051B2 (https=)
BR (1) BR112012003560A8 (https=)
CA (1) CA2771166C (https=)
CL (1) CL2012000448A1 (https=)
CO (1) CO6511227A2 (https=)
CY (1) CY1119041T1 (https=)
DK (1) DK2467465T3 (https=)
EA (1) EA023867B1 (https=)
ES (1) ES2635730T3 (https=)
GE (1) GEP20146057B (https=)
HR (1) HRP20171225T1 (https=)
HU (1) HUE036124T2 (https=)
IL (1) IL218201A (https=)
LT (1) LT2467465T (https=)
ME (1) ME02866B (https=)
MX (1) MX2012002089A (https=)
MY (1) MY156177A (https=)
NZ (1) NZ598452A (https=)
PL (1) PL2467465T3 (https=)
PT (1) PT2467465T (https=)
RS (1) RS56120B1 (https=)
SG (1) SG178521A1 (https=)
SI (1) SI2467465T1 (https=)
SM (1) SMT201700397T1 (https=)
WO (1) WO2011022682A1 (https=)
ZA (1) ZA201202075B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2720989T3 (en) 2011-06-20 2016-11-28 H Lundbeck As Deuterated 1-piperazino-3-phenyl-indanes used to treat schizophrenia
US20140079868A1 (en) * 2012-04-05 2014-03-20 Anheuser-Busch, Llc Packaging for decarbonated beer base liquid
EP4345100A3 (en) 2012-09-18 2024-04-10 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
US9713330B1 (en) 2013-03-15 2017-07-25 Deuteria Agrochemicals, Llc Deuterium-enriched aldehydes
US9023336B2 (en) 2013-03-15 2015-05-05 Deuterra Agrochemicals, LLC Deuterium-enriched aldehydes
CN107250340B (zh) * 2014-09-16 2021-05-07 罗伯特·布洛西亚 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物
US11528924B2 (en) * 2014-12-09 2022-12-20 Clearmind Medicine, Inc. Alcoholic beverage substitutes
AU2016229949B2 (en) 2015-03-06 2021-04-08 Auspex Pharmaceuticals Llc Methods for the treatment of abnormal involuntary movement disorders
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US10289381B2 (en) * 2015-12-07 2019-05-14 Motorola Mobility Llc Methods and systems for controlling an electronic device in response to detected social cues
CA3059585A1 (en) 2017-04-27 2018-11-01 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from d2o
AU2018260728B2 (en) 2017-04-27 2022-07-21 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from D2
CN109330632B (zh) * 2018-11-09 2023-09-29 上海导向医疗系统有限公司 活检旋切装置
WO2020114853A1 (en) 2018-12-03 2020-06-11 H. Lundbeck A/S Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
EP3932547A4 (en) * 2019-02-26 2022-12-07 Tsubame BHB Co., Ltd. Molded sintered body, and method for producing molded sintered body
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
CA3155035C (en) 2019-10-29 2024-06-04 William Alan BLAIR Apparatus to facilitate transfer of biological specimens stored at cryogenic conditions
US11817187B2 (en) 2020-05-18 2023-11-14 TMRW Life Sciences, Inc. Handling and tracking of biological specimens for cryogenic storage
USD963194S1 (en) 2020-12-09 2022-09-06 TMRW Life Sciences, Inc. Cryogenic vial carrier
CA3200508A1 (en) 2020-12-10 2022-06-16 TMRW Life Sciences, Inc. Specimen holder with wireless transponder for attachment to specimen collection body
EP4252009B1 (en) 2021-01-13 2025-03-05 TMRW Life Sciences, Inc. System to pick and/or place specimen containers
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof
EP4412453A4 (en) 2021-10-08 2025-01-22 TMRW Life Sciences, Inc. SYSTEMS, DEVICES AND METHODS FOR TAKING AND/OR PLACING SAMPLE CONTAINERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156408A (en) * 1974-11-08 1976-05-18 Piasu Chem Co Karubonsanno jusuisokaesuteruno seizohoho
DE3413085A1 (de) 1984-04-06 1985-10-24 Henkell & Co, 6200 Wiesbaden Verfahren zum herabsetzen des alkoholgehalts alkoholhaltiger getraenke, insbesondere wein und schaumwein
US4612196A (en) 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5223269A (en) 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
JPH05156408A (ja) * 1991-11-29 1993-06-22 Nippon Steel Corp 溶接性に優れた高強度マルテンサイトステンレス鋼とその製造方法
DE4343838C2 (de) 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
AU691483B2 (en) 1994-01-06 1998-05-21 Hyd Kutato-Fejleszto Kft. Food products for preventing development of diseases and process for preparing same
CN1143308A (zh) * 1994-01-06 1997-02-19 Hyd探索发展有限公司 预防疾病发生的食品及其制备方法
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
GB2293100A (en) 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
KR100387229B1 (ko) 1995-11-01 2003-08-21 삼성전자주식회사 영상부호화장치
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
DE10362026B4 (de) 2003-12-19 2009-01-08 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verwendung von Palatinose zur Verbesserung der Lagerungsstabilität eines bierähnlichen Erfrischungsgetränkes
AU2005327331A1 (en) * 2005-02-08 2006-08-17 Woodford Associates Limited Alcoholic beverage enriched with 1H216O
EP1934201A1 (en) * 2005-10-06 2008-06-25 Auspex Pharmaceuticals Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US7713773B2 (en) * 2005-11-02 2010-05-11 Solopower, Inc. Contact layers for thin film solar cells employing group IBIIIAVIA compound absorbers
US20080301122A1 (en) * 2007-05-31 2008-12-04 Amadeus S.A.S. Searching techniques
US20090046823A1 (en) * 2007-08-14 2009-02-19 Texas Instruments Incorporated Neutron generating device

Also Published As

Publication number Publication date
PT2467465T (pt) 2017-09-11
PL2467465T3 (pl) 2017-11-30
HUE036124T2 (hu) 2018-06-28
CA2771166C (en) 2015-02-24
AP2012006133A0 (en) 2012-02-29
MX2012002089A (es) 2012-07-03
CN103300449B (zh) 2015-05-06
EA023867B1 (ru) 2016-07-29
US10731116B2 (en) 2020-08-04
US8658236B2 (en) 2014-02-25
KR20120053510A (ko) 2012-05-25
US10047330B2 (en) 2018-08-14
IL218201A (en) 2015-09-24
HK1171245A1 (en) 2013-03-22
US9732311B2 (en) 2017-08-15
US11298317B2 (en) 2022-04-12
NZ598452A (en) 2012-12-21
US20210038511A1 (en) 2021-02-11
CN103300449A (zh) 2013-09-18
HRP20171225T1 (hr) 2017-10-20
ME02866B (me) 2018-04-20
EP2467465A1 (en) 2012-06-27
US20110046236A1 (en) 2011-02-24
US20150011651A1 (en) 2015-01-08
US20180030394A1 (en) 2018-02-01
AU2010284051B2 (en) 2014-12-04
BR112012003560A2 (pt) 2020-10-27
ES2635730T3 (es) 2017-10-04
GEP20146057B (en) 2014-03-10
CA2771166A1 (en) 2011-02-24
ZA201202075B (en) 2013-08-28
EA201290097A1 (ru) 2012-08-30
WO2011022682A1 (en) 2011-02-24
JP5862965B2 (ja) 2016-02-16
CN102471742A (zh) 2012-05-23
SG178521A1 (en) 2012-04-27
IL218201A0 (en) 2012-04-30
US20190062680A1 (en) 2019-02-28
AP3676A (en) 2016-04-16
DK2467465T3 (en) 2017-09-11
EP2467465A4 (en) 2013-09-25
CN102471742B (zh) 2013-05-29
US9044423B2 (en) 2015-06-02
LT2467465T (lt) 2017-11-27
SI2467465T1 (sl) 2017-09-29
AU2010284051A1 (en) 2012-03-08
JP2013502227A (ja) 2013-01-24
EP2467465B1 (en) 2017-06-07
RS56120B1 (sr) 2017-10-31
CL2012000448A1 (es) 2012-08-31
MY156177A (en) 2016-01-15
SMT201700397T1 (it) 2017-09-07
CO6511227A2 (es) 2012-08-31
CY1119041T1 (el) 2018-01-10
KR101462740B1 (ko) 2014-11-17
US20160137959A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
BR112012003560A8 (pt) bebida alcoólica, método de produção de uma bebida alcoólica e composição farmacêutica
MX338712B (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
BR112013000537A2 (pt) composição aquosa contendo bromexina
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
ECSP11011048A (es) Inhibidores de cinasa akt y p70 s6
BR112012011328A2 (pt) inibidores de akt
BR112014009146A8 (pt) formulações de etanercepte estabilizadas com aminoácidos
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112012022513A2 (pt) derivados de piperidin-4-il azetidina como inibidores de jak1
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
MX366925B (es) Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
EA201071167A1 (ru) Стабилизированные олеосомные композиции и способы их получения
BR112013025777A2 (pt) imidazopiridazinas como inibidores da quinase akt
BRPI0815474A8 (pt) Método para produzir um alimento ou bebida à base de malte apropriado para consumo por um indivíduo com doença celíaca
BR112014009376A2 (pt) composições
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
MX2010009147A (es) Derivados de pirrolidinilo y usos de los mismos.
CL2010001566A1 (es) Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune.
BR112013000840A2 (pt) método para aumentar o efeito de forma ativada potencializada de anticorpo para molécula endógena biológica, composição farmacêutica e uso de combinação de molécula biológica endógena com forma ativada potencializada de anticorpo para a sintase no endotelial.
BR112012016054A2 (pt) Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
BR112014032254A2 (pt) processo para a preparação de uma composição, aparelho, e, uso de um aparelho
BRPI0814808B8 (pt) processo para preparação de óleo ou manteiga de sapucainha e uso de óleo ou manteiga de sapucainha

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: DEUTERIA BEVERAGES, LLC. (US)

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870180058830 DE 06/07/2018, EM VIRTUDE DO PEDIDO JA ESTAR EM NOME DO INTERESSADO.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: PROTIA LLC (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.2 NA RPI NO 2601 DE 10/11/2020 POR TER SIDO INDEVIDA.

B25A Requested transfer of rights approved

Owner name: DEUTERIA BEVERAGES, LLC. (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]